Aardvark Therapeutics Expands Phase 3 HERO Trial Eligibility for ARD-101 in Prader-Willi Syndrome After FDA Protocol Alignment
Aardvark Therapeutics Inc. (NASDAQ:AARD) is one of the best young stocks with huge upside potential.
Aardvark Therapeutics Inc. (AARD)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Decheng Capital Min Cui | 3,917,299 | $52,961,882 | 13.38% | |
| 2. | Citadel Investment Group Ken Griffin | 1,283,732 | $17,356,057 | +1% | 0% |
| 3. | Laurion Capital Management Benjamin A. Smith | 989,068 | $13,372,199 | +23% | 0.24% |
| 4. | Cormorant Asset Management Bihua Chen | 800,189 | $10,818,555 | 0.81% | |
| 5. | SilverArc Capital Devesh Gandhi | 286,807 | $3,877,631 | +141% | 0.72% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.94 | 3,500 | $34,804.70 | 1,543,384 | 2025-09-15 | Filing | |
| $9.51 | 6,500 | $61,818.90 | 1,539,884 | 2025-09-15 | Filing | |
| $8.50 | 5,000 | $42,515.50 | 1,533,384 | 2025-09-12 | Filing | |
| $7.82 | 6,000 | $46,926.00 | 1,528,384 | 2025-09-11 | Filing | |
| $7.91 | 9,000 | $71,212.50 | 1,522,384 | 2025-09-10 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,000 | $13,290 | 0% | |
| 2. | 15 | $0 | 0% |
News See All
12 Best Young Stocks with Huge Upside Potential
On September 15, Tom Sosnoff, Tastylive founder, joined 'Squawk Box' on CNBC to discuss the state of the IPO landscape and what to make of the surge of IPO offerings.